George Clinical Expands China Team With New Project Director And Cell Gene Therapy Head Helen Xu

BEIJING, Sept 9 (Bernama-GLOBE NEWSWIRE) — George Clinical, a global clinical research organization with an extensive presence throughout the Asia-Pacific region, continues to expand the organization’s team in China with the addition of Helen Xu as Project Director and Cell Gene Therapy Head. She will be based in Beijing and joins a rapidly growing team responsible for expanding clinical research activity in China with biopharmaceutical, medical device and diagnostic sponsors.   

Dr. Xu obtained her MD in clinical medicine from Peking University Health Center. She is a licensed physician specialized in central nervous system (CNS) and has worked in the hospital setting for four years. Dr. Xu entered the pharmaceutical industry in 2007 starting as a clinical research associate (CRA) and has since accumulated 15 years of valuable clinical research experience in China. 

http://mrem.bernama.com/viewsm.php?idm=44127

administrator

Related Articles